AGL 38.00 Decreased By ▼ -0.02 (-0.05%)
AIRLINK 207.00 Increased By ▲ 9.64 (4.88%)
BOP 9.64 Increased By ▲ 0.10 (1.05%)
CNERGY 6.02 Increased By ▲ 0.11 (1.86%)
DCL 8.93 Increased By ▲ 0.11 (1.25%)
DFML 37.10 Increased By ▲ 1.36 (3.81%)
DGKC 96.94 Increased By ▲ 0.08 (0.08%)
FCCL 35.89 Increased By ▲ 0.64 (1.82%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.47 Increased By ▲ 0.30 (2.28%)
HUBC 128.01 Increased By ▲ 0.46 (0.36%)
HUMNL 13.80 Increased By ▲ 0.30 (2.22%)
KEL 5.40 Increased By ▲ 0.08 (1.5%)
KOSM 7.07 Increased By ▲ 0.07 (1%)
MLCF 45.00 Increased By ▲ 0.30 (0.67%)
NBP 60.35 Decreased By ▼ -1.07 (-1.74%)
OGDC 217.50 Increased By ▲ 2.83 (1.32%)
PAEL 40.95 Increased By ▲ 2.16 (5.57%)
PIBTL 8.43 Increased By ▲ 0.18 (2.18%)
PPL 194.89 Increased By ▲ 1.81 (0.94%)
PRL 39.27 Increased By ▲ 0.61 (1.58%)
PTC 26.70 Increased By ▲ 0.90 (3.49%)
SEARL 107.49 Increased By ▲ 3.89 (3.75%)
TELE 8.50 Increased By ▲ 0.20 (2.41%)
TOMCL 35.70 Increased By ▲ 0.70 (2%)
TPLP 13.50 Increased By ▲ 0.20 (1.5%)
TREET 23.15 Increased By ▲ 0.99 (4.47%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.16 Increased By ▲ 0.19 (0.58%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 11,931 Increased By 204.6 (1.75%)
BR30 36,882 Increased By 505.5 (1.39%)
KSE100 111,998 Increased By 2484.8 (2.27%)
KSE30 35,279 Increased By 765.7 (2.22%)
Business & Finance

Germany expects 40.2mn doses of Biontech COVID vaccine in Q2

  • The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday.
Published February 1, 2021

BERLIN: The German government expects 40.2 million doses of Biontech/Pfizer's COVID-19 vaccine in the second quarter, a government document seen by Reuters on Monday showed.

The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday, also said that the government sees potential delivery and production risks.

Comments

Comments are closed.